QORVO INC. - COMMON STOCK

Qorvo® Announces Appointment of Philip Chesley as President of Infrastructure & Defense Products

03 Nov 2021 16:10:00 By Nasdaq GlobeNewswire

Qorvo® Announces Fiscal 2022 Second Quarter Financial Results

03 Nov 2021 16:01:01 By Nasdaq GlobeNewswire

Qorvo® to Webcast Quarterly Earnings Conference Call on November 3, 2021

20 Oct 2021 08:00:01 By Nasdaq GlobeNewswire

Qorvo® Announces Fiscal 2022 First Quarter Financial Results

04 Aug 2021 16:00:00 By Nasdaq GlobeNewswire

Qorvo Biotechnologies Omnia™ SARS-CoV-2 Antigen Test Platform Validated in National Institutes of Health (NIH) Funded Study

28 Jul 2021 16:01:00 By Nasdaq GlobeNewswire

Qorvo® to Webcast Quarterly Earnings Conference Call on August 4, 2021

21 Jul 2021 08:00:01 By Nasdaq GlobeNewswire

Qorvo Advances Radar Architecture with Reconfigurable Dual-band GaN Power Amplifier MMICs

21 Jun 2021 08:00:01 By Nasdaq GlobeNewswire

Qorvo® Solutions Interoperable with Apple* U1 Chip for New Ultra-Wideband Enabled Experiences

07 Jun 2021 16:01:00 By Nasdaq GlobeNewswire

Qorvo® to Present at the Bank of America Securities 2021 Global Technology Conference

01 Jun 2021 08:00:01 By Nasdaq GlobeNewswire

Qorvo® Recognized by Samsung for Best Quality in Mobile

27 May 2021 08:00:02 By Nasdaq GlobeNewswire

Qorvo® to Present at the J.P. Morgan Global Technology, Media and Communications Conference

18 May 2021 16:00:00 By Nasdaq GlobeNewswire

Qorvo® Appoints Judy Bruner to its Board of Directors

12 May 2021 16:01:00 By Nasdaq GlobeNewswire

Qorvo® Acquires Leading MEMS-based Sensor Solution Provider NextInput

06 May 2021 08:00:02 By Nasdaq GlobeNewswire

Qorvo® Announces Fiscal 2021 Fourth Quarter Financial Results

05 May 2021 16:00:00 By Nasdaq GlobeNewswire

Qorvo® to Webcast Quarterly Earnings Conference Call on May 5, 2021

21 Apr 2021 08:00:01 By Nasdaq GlobeNewswire

Qorvo Biotechnologies Awarded $24.4 Million National Institutes of Health Contract to Scale Point-of-Care COVID-19 Antigen Testing

15 Apr 2021 16:06:00 By Nasdaq GlobeNewswire

Qorvo® Biotechnologies Receives FDA Emergency Use Authorization (EUA) for Rapid COVID-19 Antigen Testing

15 Apr 2021 16:01:00 By Nasdaq GlobeNewswire

Qorvo® Accelerates 5G Smartphone Design with RF Fusion20™

24 Mar 2021 08:00:00 By Nasdaq GlobeNewswire

Qorvo® Launches First Smart Home Device Controller to Support Simultaneous Wireless Communications

22 Mar 2021 08:00:01 By Nasdaq GlobeNewswire

Qorvo® to Present at the Morgan Stanley Technology, Media and Telecom Conference

25 Feb 2021 08:00:02 By Nasdaq GlobeNewswire